What is the Impact Factor of Cancer Letters?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Cancer Letters is 11.8, ranking in quartile Q1 of Web of Science (SCIE).

Is Cancer Letters indexed in Web of Science or Scopus?

Yes, Cancer Letters is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 3.066 (Q1) and an H-index of 240.

Who publishes Cancer Letters and what is the Article Processing Charge (APC)?

Cancer Letters is published by Elsevier Ireland Ltd. The estimated Article Processing Charge (APC) is approximately $3,938 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Cancer Letters?

The official ISO-4 abbreviation of Cancer Letters is "CANCER LETT" with common acronym "canlet". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #688Top JournalHybrid

Cancer Letters

Acronym:canlet

•

Abbreviation (ISO):CANCER LETT

•

Identifier (ISSN):0304-3835(Print)/1872-7980(Online)

•

Publisher:Elsevier Ireland Ltd

Official Website Submission Portal Compare

Clarivate IF (2026)

11.8↑ +1.7

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Letters

WoS Q1

Annual Impact Factor Metric

Current (2026):11.8

Scopus SJR & RankScopus Q1

3.066

#688

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

240

240 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate6.6%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

511articles/year

27.9% Gold OA•95.22% Original Research

Aims & Scope

CANCER LETTERS is a journal providing rapid publication of full-length articles in the broad area of cancer research. The journal places emphasis on the molecular and cell biology of cancer, oncogenes, carcinogenesis, radiation biology, molecular pathology, hormones and cancer, viral oncology, biology of cancer and metastasis, molecular cytogenetics, epidemiology; and experimental therapeutics. The primary criterion for publication is interest to a multidisciplinary audience. Papers should be technically sound and substantiated by sufficient experimental detail. Clinical papers will be accepted if they contribute to the understanding of the basic mechanisms underlying disease.

Topics Covered (Recognized by AI)

Medicine93.8%Biology91.4%Genetics88.8%Chemistry86.6%Biochemistry82.7%Internal medicine81.4%Cancer57.1%Cancer research55.2%Gene53.6%Organic chemistry34.5%Cell biology32.7%Pathology32.3%Immunology30.2%Endocrinology29.6%Physics29.3%In vitro24.8%Apoptosis24.3%Cell culture24.1%Molecular biology21.6%

Primary Research Areas

Medicine Oncology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile 3 Calls for Papers

3 calls

Special Issues

Calls for Papers

3 Calls for Papers · Automatically synced from ScienceDirect & publishers

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank29/333

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank24/333

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	29/333	Q1
ONCOLOGY	JCISCIE	24/333	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF11.8

Articles / Year472

Total Citations470

2025

IF10.1

Articles / Year598

Total Citations4,752

2024

IF9.1

Articles / Year629

Total Citations12,524

2023

IF9.7

Articles / Year375

Total Citations10,392

2022

IF9.756

Articles / Year366

Total Citations11,918

Year	Impact Factor	Articles / Year	Total Citations
2026	11.8	472	470
2025	10.1	598	4,752
2024	9.1	629	12,524
2023	9.7	375	10,392
2022	9.756	366	11,918
2021	8.679	472	22,023
2020	7.36	496	27,042
2019	6.508	479	33,314
2018	6.491	547	30,589
2017	—	509	35,253
2016	—	527	36,036
2015	—	489	35,997

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #688Scopus Q1SCImago Profile

Scopus Coverage:1975-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q1

3.066

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

11.29

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,938 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations12,959

3-Year Documents1,241

Citable Documents1,220

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1

OncologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 6.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

1区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Letters (acronym: canlet, abbr: CANCER LETT, ISSN: 0304-3835) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Ireland Ltd in Netherlands since 1975. The periodical holds a Journal Impact Factor (JIF) of 11.8, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.066 (Q1), an H-index of 240.

The journal enforces rigorous peer evaluation with an average review speed of 3.3周, a publication frequency of Biweekly, an annual output of approximately 511 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,938 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.